InsidersTradesSigma
Browse the detailed record of transactions filed by Sholehvar David, Président. Officer active across 1 company, notably Neogenomics INC. Aggregated, 1 reports have been logged. Activity tracked since 1 April 2022. The latest transaction was filed on 1 April 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
1 of 1 declaration
David Sholehvar is the President of Clinical Services at Neogenomics Inc. In this role, he oversees the clinical operations of the company, which provides molecular diagnostic services. David is an experienced leader in the healthcare field, contributing to the enhancement of services offered to patients.